Dr. Khosla is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Mayo Clin, Div Endocrinology
Rochester, MN 55905Phone+1 507-284-2511
Summary
- Dr. Sundeep Khosla is an endocrinologist based in Rochester, MN, specializing in diabetes, lipid metabolism, osteoporosis, and bone metabolism medicine. He completed his medical education at Harvard Medical School in 1982, followed by a residency in internal medicine and a fellowship in endocrinology, diabetes, and metabolism at Massachusetts General Hospital. Since 1988, he has been serving as an attending physician at Mayo Clinic Hospital in Rochester. His expertise includes osteoporosis and age-related bone loss, and he has contributed to the field through numerous publications in high-profile journals. Dr. Khosla is involved in clinical trials focusing on frailty and inflammation in older adults. He has been recognized as one of America's Top Doctors and is an elected member of both the American Society for Clinical Investigation and the Association of American Physicians.
Education & Training
- Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1986 - 1987
- Massachusetts General HospitalResidency, Internal Medicine, 1982 - 1985
- Harvard Medical SchoolClass of 1982
Certifications & Licensure
- MN State Medical License 1988 - 2025
- AZ State Medical License 1992 - 2005
- FL State Medical License 1991 - 2000
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Elected Member The American Society for Clinical Investigation, 2003
- Elected Member Association of American Physicians
Clinical Trials
- Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Women Start of enrollment: 2018 Feb 06
- Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Adults Start of enrollment: 2018 Nov 15
Publications & Presentations
PubMed
- Rheumatoid arthritis and subsequent fracture risk: an individual person meta-analysis to update FRAX.John A Kanis, Helena Johansson, Eugene V McCloskey, Enwu Liu, Marian Schini
Osteoporosis International. 2025-02-16 - Pharmacogenetic and microRNA mechanisms of beta blocker use on bone.Christine W Lary, Elizabeth J Atkinson, Jennifer Spillane, Zannatun Nayema, Tyler A Roy
Journal of Bone and Mineral Research. 2025-02-02 - Characterization of Human Senescent Cell Biomarkers for Clinical Trials.Joshua N Farr, David G Monroe, Elizabeth J Atkinson, Mitchell N Froemming, Ming Ruan
Aging Cell. 2025-01-17
Journal Articles
- miR‐219a‐5p Regulates Rorβ During Osteoblast Differentiation and in Age‐Related Bone LossSundeep Khosla, MD, Journal of Bone and Mineral Research
- Senolytics Improve Physical Function and Increase Lifespan in Old AgeJames L Kirkland, Nathan K LeBrasseur, S John Weroha, Vesna D Garovic, Sundeep Khosla, Allyson K Palmer, Nature
Press Mentions
- Zombie Cell Killers: New Hope for Aging BonesNovember 1st, 2024
- Is Killing 'Zombie' Cells the Key to Healthier Aging?July 3rd, 2024
- Study Highlights the Lag in Screening and Treatment of OsteoporosisDecember 20th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: